Wendy Saffell-Clemmer

home / authors / wendy-saffell-clemmer-1

Wendy Saffell-Clemmer, BPS, is research director, R&D and innovation, at Baxter Healthcare.

Articles

Impact of PFS and Filling Process Selection on Biologic Product Stability

Impact of PFS and Filling Process Selection on Biologic Product Stability

Wendy Saffell-Clemmer
April 1st 2017

The author discusses the impact of prefilled syringe product contact materials and the filling and stoppering process on protein aggregates.

A Case Study of Developing Analytical Methods

A Case Study of Developing Analytical Methods

Elizabeth Oslos;Nathan Pease;Reuben Lidster;Eddie Massey;David Gooding;Wendy Saffell-Clemmer
April 1st 2005

Contract manufacturers must plan for increased analytical resources in development and quality control.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: October 28th 2024 | Updated: November 22nd 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 15th 2024 | Updated: November 22nd 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 22nd 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 22nd 2024 | Updated: November 22nd 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
© 2024 MJH Life Sciences

All rights reserved.